<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Farhad Moegis</style></author><author><style face="normal" font="default" size="100%">Ahmad Yudianto</style></author><author><style face="normal" font="default" size="100%">Renny Sumino</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cerebral Vessel Rupture Leading to Sudden Death: Implications for Pharmacognosy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cardiovascular Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">ICH</style></keyword><keyword><style  face="normal" font="default" size="100%">SAH</style></keyword><keyword><style  face="normal" font="default" size="100%">Stroke</style></keyword><keyword><style  face="normal" font="default" size="100%">sudden death</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1442-1446</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Sudden death is one of the situations that necessitates immediate treatment from a forensic doctor. The WHO defines sudden death as death occurring within 24 hours of the beginning of symptoms. There are three sorts of sudden death: unexpected, unwitnessed, and spontaneous. Diseases of the Central Nervous System are the third most common cause of sudden death. Ischemic stroke (blockage) and hemorrhagic stroke (bleeding) are examples of central nervous system illnesses. Hypertension (cardiovascular disease) and smoking are known risk factors for hemorrhagic stroke.In 2019, the global incidence of intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) was 14.46 per 100,000 people. The case discussed in our paper is about the sudden death of a European (Ukrainian) ship captain who happened to be anchored in the waters of Gresik, East Java, who died of hemorrhagic stroke.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Case Report</style></work-type><section><style face="normal" font="default" size="100%">1442</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Farhad Moegis&lt;sup&gt;1&lt;/sup&gt;, Ahmad Yudianto&lt;sup&gt;2&lt;/sup&gt;, Renny Sumino&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Forensic Medicine and Medicolegal, Faculty of Medicine, Universitas Airlangga, dr.Soetomo General Hospital Surabaya, Surabaya, East Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Forensic Science, Postgraduate School, Universitas Airlangga, Surabaya, East Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Meity Ardiana</style></author><author><style face="normal" font="default" size="100%">Nastiti Imana Intansari</style></author><author><style face="normal" font="default" size="100%">Asiyah Nurul Fadila</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Consequences of Hypertension and Obesity on Coronary Heart Disease</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Body Mass Index</style></keyword><keyword><style  face="normal" font="default" size="100%">Cardiovascular Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Coronary Heart Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">High blood pressure</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesia</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">1331-1335</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Coronary heart disease (CHD) is the leading cause of death worldwide. At present, more than 20 million adults suffer from CHD, and the number keeps increasing. Hypertension and obesity, known risk factors of CHD, are also inclining in prevalence. Given the diversities of world population, studies on correlation of hypertension and obesity in the incidence of CHD still have a lot to unveil. &lt;strong&gt;Aim:&lt;/strong&gt; to analyze the association between hypertension and obesity to CHD as both independent and dependent risk factors. &lt;strong&gt;Method: &lt;/strong&gt;A cross-sectional descriptive study on 100 hypertensive subjects was conducted from March to November 2022. Subjects were selected by simple random sampling technique. The data were collected by anamnesis, physical examination, laboratory examination, electrocardiography, and by checking on medical records if needed. Statistical analysis was conducted using SPSS. &lt;strong&gt;Result:&lt;/strong&gt; The mean age of the study samples was 58.64 years old. The mean value of BMI was 25.77 ± 5.21 SD, and 53.6% of the participants was obese. 33% of the subjects were diagnosed with CHD. There was no correlation between obesity and CHD (OR = 0.582, 95% CI = 0.245-1.382); between hypertension on therapy or without therapy and CHD (OR= 0.729, 95% CI= 0.15-15.09). There was also no correlation between length of hypertension and CHD (R= 0.117; p = 0.27). &lt;strong&gt;Conclusion: &lt;/strong&gt;This study shows no significant correlations between hypertension, obesity, and CHD. Whether socioeconomic and demographic profile play a part in the association of hypertension and obesity with CHD, specifically for Indonesian ethnicities, should be studied further.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1331</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Meity Ardiana¹'², Nastiti Imana Intansari¹'²*, Asiyah Nurul Fadila¹'²&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Cardiology and Vascular Medicine, Dr. Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Haider Nasser Jabber</style></author><author><style face="normal" font="default" size="100%">Bassem Charfeddine</style></author><author><style face="normal" font="default" size="100%">Hamed Jaddoa Abbas</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of Tumor Necrosis Factor Alpha, Insulin, glucose, HbA1c% and HOMA-IR as Predictors for Cardiovascular Diseases in Patients with Type 2 Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cardiovascular Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Diabetes Mellitus and Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">HOMA-IR</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin</style></keyword><keyword><style  face="normal" font="default" size="100%">TNFα</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">195-201</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Comparison of the blood level of TNFα in patients with and without type 2 diabetes who have cardiovascular diseases. Examine the connection between the amount of serum TNFα and insulin resistance in patients with type 2 diabetes who have cardiovascular diseases. &lt;strong&gt;Method:&lt;/strong&gt; The present study included 60 patients with Diabetes Mellitus (DM) with a mean age of 56.02±1.395 years and an age range of (40 - 80)years and 60 patients with cardiovascular diseases and diabetes (CVD and DM) with a mean age of 59.20±1.478 and an age range of (40-80) years, Who visited Al-Basrah Teaching Hospital in Basrah. in addition, the study included 60 healthy controls mean age of healthy control subjects was 54.72±1.405years. All patients in this study were diagnosed by specialized doctors and the diagnosis was verified by clinical and laboratory tests, during the period from September 2022 to September 2023. All Subjects signed a written informed consent form. The BMI was calculated as body weight (kg) and was divided by squared height in meters. &lt;strong&gt;Results:&lt;/strong&gt; The results of this study showed an increase in the level of glucose, haemoglobin A1c%, insulin, and HOMA IR (in CVD and DM patients as compared with DM patients and control and there was a significant difference in concentrations among study groups (p-value &amp;lt;0.0001). Also, The results of this study showed an increase in the level of tumor necrosis factor-alpha in CVD and DM patients as compared with DM and control and there was a significant difference in concentrations of TNFα among study groups (p-value &amp;lt;0.0001). &lt;strong&gt;Conclusion: &lt;/strong&gt;Based on the findings of this research, it can be inferred that TNFα and HbA1c have the potential to serve as practical and straightforward indicators for predicting the coexistence of insulin resistance, dysglycemia, and Cardiovascular Diseases in seemingly healthy individuals within the young (&amp;lt;50 years) Al-Basra community.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">195</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Haider Nasser Jabber&lt;sup&gt;1,2,&lt;/sup&gt;*, Bassem Charfeddine&lt;sup&gt;2&lt;/sup&gt;, Hamed Jaddoa Abbas&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;College of Pharmacy, Basra University, Basrah, IRAQ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biochemistry, Faculty of Medicine, University of Sousse, TUNISIA. 3Al-Fayhaa Teaching Hospital – Al- Zahraa Medical college- Basrah University, Basrah, IRAQ.&lt;/p&gt;
</style></auth-address></record></records></xml>